Search

Search Bar
13/06/2023 Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate-to-severe plaque psoriasis patients in conditions close to clinical practice
Costanzo A., Llamas-Velasco M., Fabbrocini G., Cuccia A., Rivera-Diaz R., Du Jardin, KG, Kasujee I., Puig L., Carrascosa J.M.. Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate-to-severe plaque psoriasis patients in conditions close to clinical practice. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(10)DOI:10.1111/jdv.19229. PMID:37246505. IF:8.500(Q1/1D).
09/06/2023 EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis
Zabotti, A, De Marco, G, Gosset, L, Baraliakos, X, Aletaha, D, Iagnocco, A, Gisondi, P, Balint, PV, Bertheussen, H, Boehncke, WH, Damjanov, NS, de Wit, M, Errichetti, E, Marzo-Ortega, H, Protopopov, M, Puig, L, Queiro, R, Ruscitti, P, Savage, L, Schett, G, Siebert, S, Stamm, TA, Studenic, P, Tinazzi, I, Van den Bosch, FE, van der Helm-van Mil, A, Watad, A, Smolen, JS, McGonagle, DG. EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis. ANNALS OF THE RHEUMATIC DISEASES. 2023; 82(9)DOI:10.1136/ard-2023-224148. PMID:37295926. IF:20.300(Q1/1D).
01/06/2023 Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies
Sanchez-Rodriguez, G, Puig, L. Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(12)DOI:10.3390/ijms241210305. PMID:37373452. IF:4.900(Q1/3D).
31/05/2023 Real-world experience with vismodegib on advanced and multiple BCCs: data from the RELIVIS study
Ruiz-Salas, V, Podlipnik, S, Sandoval-Clavijo, A, Sanmartin-Jimenez, O, Bernia-Petit, E, Bonfill-Orti, M, Bassas-Freixas, P, Yebenes-Marsal, M, Florez-Menendez, A, Sola-Ortigosa, J, Just-Sarobe, M, Aguayo-Ortiz, RS, Niubo, EMI, Quintana-Codina, M, Deza, G, Jaka, A, Fuentes, MJ, Canueto, J, Toll, A. Real-world experience with vismodegib on advanced and multiple BCCs: data from the RELIVIS study. DERMATOLOGY. 2023; 239(5)DOI:10.1159/000530813. PMID:37257423. IF:3.000(Q2/4D).
02/05/2023 A multicenter case-control study comparing sun exposure habits and use of photoprotection measures in patients diagnosed with different types of skin cancer
Navarro-Bielsa A., Gracia-Cazaña T., Almagro M., De la Fuente-Meira, S, Florez Á., Yélamos O., Montero-Vilchez T., González-Cruz C., Diago A., Abadías-Granado I., Fuentelsaz V., Colmenero M., Banuls, J, Arias-Santiago S., Buendía-Eisman A., Almenara-Blasco M., Gil-Pallares P., Gilaberte Y.. A multicenter case-control study comparing sun exposure habits and use of photoprotection measures in patients diagnosed with different types of skin cancer. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE. 2023; 39(5)DOI:10.1111/phpp.12878. PMID:37130164. IF:2.500(Q2/4D).
01/05/2023 Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts
Carrascosa, JM, Vilarrasa, E, Belinchon, I, Herranz, P, Crespo, J, Guimera, F, Olveira, A. Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts. Actas Dermo-Sifiliograficas. 2023; 114(5)DOI:10.1016/j.ad.2023.01.004. PMID:36720362. IF:(Q/D).